ExtaviPro 30G auto-injector by Cambridge Consultants and Novartis

Product design and development firm Cambridge Consultants has worked with leading pharmaceutical company Novartis and medical device manufacturer Owen Mumford – plus hundreds of MS patients – to come up with the ExtaviPro 30G auto-injector.

ExtaviPro 30G has an attractive visual design and ergonomic shape to its easy-to-read adjustable needle depth control. The ExtaviPro 30G is aimed at people who suffer from relapsing forms of MS – such as clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS) and secondary-progressive MS (SPMS) – who make up the majority of MS patients. The ExtaviPro 30G auto-injector has been launched in Europe, initially in Germany.

Contact Details:
Website: www.CambridgeConsultants.com